Research team from University of Göttingen develops drug approach against bacterial infections
Antibiotics are among the most important discoveries of modern medicine and have saved millions of lives since the discovery of penicillin almost 100 years ago. Many diseases caused by bacterial infections – such as pneumonia, meningitis or septicaemia – are successfully treated with antibiotics. However, bacteria can develop resistance to antibiotics which then leaves doctors struggling to find effective treatments. Particularly problematic are pathogens which develop multi-drug resistance and are unaffected by most antibiotics. This leads to severe disease progression in affected patients, often with a fatal outcome. Scientists all over the world are therefore engaged in the search for new antibiotics. Researchers at the University of Göttingen and the Max Planck Institute for Biophysical Chemistry Göttingen have now described a promising new approach involving “antivitamins” to develop new classes of antibiotics. The results were published in the journal Nature Chemical Biology.
Antivitamins are substances that inhibit the biological function of a genuine vitamin. Some antivitamins have a similar chemical structure to those of the actual vitamin whose action they block or restrict. For this study, Professor Kai Tittmann’s team from the Göttingen Center for Molecular Biosciences at the University of Göttingen worked together with Professor Bert de Groot’s group from the Max Planck Institute for Biophysical Chemistry Göttingen and Professor Tadgh Begley from Texas A&M University (USA). Together they investigated the mechanism of action at the atomic level of a naturally occurring antivitamin of vitamin B1. Some bacteria are able to produce a toxic form of this vital vitamin B1 to kill competing bacteria. This particular antivitamin has only a single atom in addition to the natural vitamin in a seemingly unimportant place and the exciting research question was why the action of the vitamin was still prevented or “poisoned”.
Tittmann’s team used high-resolution protein crystallography to investigate how the antivitamin inhibits an important protein from the central metabolism of bacteria. The researchers found that the “dance of the protons”, which can normally be observed in functioning proteins, almost completely ceases to function and the protein no longer works. “Just one extra atom in the antivitamin acts like a grain of sand in a complex gear system by blocking its finely tuned mechanics,” explains Tittmann. It is interesting to note that human proteins are able to cope relatively well with the antivitamin and continue working. The chemist de Groot and his team used computer simulations to find out why this is so. “The human proteins either do not bind to the antivitamin at all or in such a way that they are not ‘poisoned’,” says the Max Planck researcher. The difference between the effects of the antivitamin on bacteria and on human proteins opens up the possibility of using it as an antibiotic in the future and thus creating new therapeutic alternatives.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Penicillin Developmentson April 6, 2021 at 4:28 am
Please use one of the following formats to cite this article in your essay, paper or report: APA Meštrović, Tomislav. (2021, April 06). Penicillin Developments. News-Medical. Retrieved on April ...
- Dietary Supplements and Minerals Newson April 2, 2021 at 5:00 pm
Mar. 25, 2021 — Fish oil supplements are a billion-dollar industry built on a foundation of purported, but not proven, health benefits. Now, new research indicates that taking fish oil only ...
- Antibiotics Newson April 29, 2012 at 7:47 am
A new class of antibiotics, called immuno-antibiotics, may present the answer. Are antivitamins the solution to the antimicrobial resistance problem? Microbiologists have now identified a new ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- Dr. Keith Roach: How to determine if a UTI is new or just recurringon April 11, 2021 at 10:20 pm
Dear Dr. Roach • I have a problem with chronic urine infections. I am 78 years old, and suffer often from it. I frequently go to the bathroom five or ...
- Why COVID is just the tip of a terrifying, but potentially revolutionary, antibiotic resistant icebergon April 9, 2021 at 10:25 am
Although no new class of antibiotics has been brought to the market for decades, new developments in treatments for bacterial infection are providing glints of hope. 43 new antibiotics are being ...
- Molecule could beat antibiotic-resistant infectionson April 8, 2021 at 7:08 am
By using their knowledge of how bacteria co-exist and compete with one another in nature, Western University researchers have discovered a compound that can inhibit the growth of Staphylococcus aureus ...
- Antibiotic Alternatives Stimulate New Product Development in Global Animal Feed Ingredient Marketon April 8, 2021 at 4:03 am
Global Animal Feed Ingredient Market Powered by Antibiotic Alternatives and Vertical Integration is the latest addition to Frost & Sullivan's Chemicals, Materials and Nutrition research and ...
- Bacterial "homing missiles" could unlock new antibiotic treatmentson April 7, 2021 at 11:19 pm
They’ll often use specialized toxins, which is where many of our antibiotics come from ... outweigh the cost to the individual. For the new study, researchers at Lawrence Berkeley National ...